α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons (Q34503671)

2 August 2017

title

α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons (English)

1 reference

2 August 2017

0 references

1 reference

6

Anders Björklund

0 references

author name string

Mickael Decressac

1

1 reference

2 August 2017

Banafsheh Kadkhodaei

2

1 reference

2 August 2017

Bengt Mattsson

3

1 reference

2 August 2017

Ariadna Laguna

4

1 reference

2 August 2017

Thomas Perlmann

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Science Translational Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

163

1 reference

2 August 2017

page(s)

163ra156

1 reference

Priorities in Parkinson's disease research

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Repairing the parkinsonian brain with neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Localized striatal delivery of GDNF as a treatment for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Trophic factors therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Type 2 diabetes in childhood: the American perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Crossroads in GDNF therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Neurotoxic in vivo models of Parkinson's disease recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Parkinson's disease and α-synuclein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

α-Synuclein and dopamine at the crossroads of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Repression of alpha-synuclein expression and toxicity by microRNA-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Nurr1 in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Nuclear localization of alpha-synuclein and its interaction with histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Dopamine neuron agenesis in Nurr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Is CREB a key to neuronal survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Absolute requirement of GDNF for adult catecholaminergic neuron survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Mutations in NR4A2 associated with familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Characterisation of a novel NR4A2 mutation in Parkinson's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

MicroRNA-124 is a subventricular zone neuronal fate determinant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Production methods for gene transfer vectors based on adeno-associated virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004676

10.1126/SCITRANSLMED.3004676

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference